These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29234909)

  • 41. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions.
    Desai RJ; Huybrechts KF; Bateman BT; Hernandez-Diaz S; Mogun H; Gopalakrishnan C; Patorno E; Kim SC
    Arthritis Rheumatol; 2016 May; 68(5):1183-9. PubMed ID: 26606742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Which dose of steroids and which cytotoxics for severe lupus?
    Lutalo PM; Jordan N; D'Cruz DP
    Presse Med; 2014 Jun; 43(6 Pt 2):e157-65. PubMed ID: 24882275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The egg and I: preserving fertility in systemic lupus erythematosus.
    Petri M
    Lupus; 2000; 9(6):399-400. PubMed ID: 10981641
    [No Abstract]   [Full Text] [Related]  

  • 44. Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al.
    Costedoat-Chalumeau N; Amoura Z; Marra D; Piette JC
    Arthritis Rheum; 2008 Jan; 59(1):153; author reply 153-4. PubMed ID: 18163410
    [No Abstract]   [Full Text] [Related]  

  • 45. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
    Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
    Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
    Takizawa Y; Maruyama J; Setoguchi K
    Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
    [No Abstract]   [Full Text] [Related]  

  • 47. Rituximab in lupus and beyond: the state of the art.
    Hughes G
    Lupus; 2009 Jun; 18(7):639-44. PubMed ID: 19433465
    [No Abstract]   [Full Text] [Related]  

  • 48. Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study.
    Piga M; Gabba A; Cauli A; Garau P; Vacca A; Mathieu A
    Lupus; 2013 May; 22(6):624-8. PubMed ID: 23559669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of experimental systemic lupus erythematosus.
    Mozes E; Segal R; Sthoeger Z; Dayan M; Zinger H; Kohn LD; Singer DS
    Isr J Med Sci; 1996 Jan; 32(1):19-21. PubMed ID: 8550341
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful Treatment with Rituximab in a Patient with Castleman's Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia.
    Zhang L; Jiao L; Wang SJ
    Chin Med J (Engl); 2015 Sep; 128(18):2551-2. PubMed ID: 26365980
    [No Abstract]   [Full Text] [Related]  

  • 51. Systemic lupus erythematosus and psoriasis: a new case.
    Ben Dhaou B; Aydi Z; Baili L; Ketari S; Boussema F; Rokbani L
    Tunis Med; 2013 Dec; 91(12):737. PubMed ID: 24458680
    [No Abstract]   [Full Text] [Related]  

  • 52. Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.
    Beccastrini E; D'Elios MM; Emmi G; Silvestri E; Squatrito D; Prisco D; Emmi L
    Int J Immunopathol Pharmacol; 2013; 26(3):585-96. PubMed ID: 24067455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetic modeling of therapies for systemic lupus erythematosus.
    Yang X; Sherwin CM; Yu T; Yellepeddi VK; Brunner HI; Vinks AA
    Expert Rev Clin Pharmacol; 2015; 8(5):587-603. PubMed ID: 26143647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab in the treatment of bullous systemic lupus erythematosus.
    Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
    J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic lupus erythematosus.
    Kiriakidou M; Cotton D; Taichman D; Williams S
    Ann Intern Med; 2013 Oct; 159(7):ITC4-1. PubMed ID: 24081299
    [No Abstract]   [Full Text] [Related]  

  • 57. Chylothorax as the initial presentation of systemic lupus erythematosus: a case report.
    Lin YJ; Chen DY; Lan JL; Hsieh TY
    Clin Rheumatol; 2007 Aug; 26(8):1373-4. PubMed ID: 16927041
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapeutic efficacy and safety profile of infliximab in active systemic lupus erythematosus.
    Hayat SJ; Uppal SS
    Mod Rheumatol; 2007; 17(2):174-7. PubMed ID: 17437178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
    Chiang E; Jampol LM; Fawzi AA
    Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
    [No Abstract]   [Full Text] [Related]  

  • 60. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.